Search

everythinglearnresearchcommunity

for

Search:↓

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Using finasteride with TIP extends time off period for prostate cancer patients.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Taking 5-Alpha Reductase Inhibitors before bladder removal surgery might make high-grade bladder tumors less aggressive.

Disrupting the Flcn gene in mice causes early kidney cysts and tumors, which can be treated with rapamycin.

Removing integrin α3β1 from hair stem cells lowers skin tumor growth by affecting CCN2 protein levels.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

Early diagnosis and treatment, using finasteride, minoxidil, or hair transplantation, improves hair loss outcomes.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Dutasteride is more efficient than finasteride, but individual results vary.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

The document discusses male and female pattern hair loss, its diagnosis methods, FDA-approved treatments like finasteride and minoxidil, their side effects, and the role of lifestyle changes.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Histone demethylases play a key role in the development of many diseases and may be targets for treatment.

GRK2 is essential for healthy hair follicle function, and its absence can lead to hair loss and cysts.

A group has developed therapies that show promise for treating cancer and various other conditions.

Keratin proteins are essential for keeping the cells in the human colon healthy and stable.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

High amphiregulin in the skin is a bad sign for acute graft-versus-host disease.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

Certain drugs that block specific enzymes can help treat prostate diseases.

Saw palmetto extract may help treat brain tumors by blocking a specific growth signal and blood vessel formation.

The meeting showcased rare skin disease cases, highlighting the need for accurate diagnosis and treatment.

Finasteride improves prostate cancer detection in PSA test.